Nu Skin Enterprises (NYSE: NUS – Get Assessed) saw its target price drop by analysts DA Davidson from $40.00 to $34.00 in a research note released Wednesday to investors, Stock Target Advisor reports. The brokerage currently has a “neutral” rating on the stock. DA Davidson’s price target would suggest a potential decline of 13.62% from the company’s previous close.
NUS has been the subject of a number of other research reports. StockNews.com upgraded Nu Skin Enterprises shares from a “hold” rating to a “buy” rating in a Friday, Nov. 4 research report. Citigroup reduced its target price on Nu Skin Enterprises from $39.00 to $35.00 in a Friday, November 4 research report. Finally, TheStreet downgraded shares of Nu Skin Enterprises from a “b” rating to a “c” rating in a Thursday, August 4, report.
Nu Skin Enterprises stock up 4.2%
Shares of NUS opened at $39.36 on Wednesday. Nu Skin Enterprises has a 12 month minimum of $29.95 and a 12 month maximum of $56.76. The company has a quick ratio of 1.23, a current ratio of 2.13 and a leverage ratio of 0.45. The company has a market capitalization of $1.95 billion, a PE ratio of 53.19 and a beta of 1.22. The stock has a 50-day moving average of $36.59 and a 200-day moving average of $41.36.
Insider Buying and Selling at Nu Skin Enterprises
In other news, Director Andrew D. Lipman sold 1,000 shares of Nu Skin Enterprises in a trade that took place on Tuesday, November 22. The shares were sold at an average price of $38.16, for a total value of $38,160.00. Following completion of the transaction, the administrator now owns 67,393 shares of the company, valued at $2,571,716.88. The transaction was disclosed in a filing with the Securities & Exchange Commission, accessible via this hyperlink. In other news, CEO Ryan S. Napierski sold 25,000 shares of the company in a trade Thursday, August 25. The stock was sold at an average price of $42.99, for a total value of $1,074,750.00. Following the completion of the sale, the CEO now directly owns 122,683 shares of the company, valued at $5,274,142.17. The sale was disclosed in a filing with the SEC, accessible via this link. Additionally, director Andrew D. Lipman sold 1,000 shares of the company in a trade dated Tuesday, November 22. The stock was sold at an average price of $38.16, for a total transaction of $38,160.00. Following the transaction, the administrator now owns 67,393 shares of the company, valued at approximately $2,571,716.88. The disclosure of this sale can be found here. Insiders sold a total of 29,602 shares of the company worth $1,248,282 in the past ninety days. Company insiders own 2.80% of the company’s shares.
Nu Skin Enterprises Institutional Trade
Hedge funds and other institutional investors have recently changed their stock holdings. The Kentucky State Teachers’ Retirement System purchased a new position in Nu Skin Enterprises in Q3 worth $339,000. BNP Paribas Arbitrage SNC increased its position in Nu Skin Enterprises shares by 185.5% during the third quarter. BNP Paribas Arbitrage SNC now owns 54,639 shares in the company worth $1,823,000 after purchasing an additional 35,500 shares during the period. State Street Corp increased its position in Nu Skin Enterprises shares by 3.3% during the third quarter. State Street Corp now owns 9,466,774 shares of the company worth $315,906,000 after purchasing an additional 305,539 shares during the period. Thrivent Financial for Lutherans increased its stake in Nu Skin Enterprises shares by 220.3% during the third quarter. Thrivent Financial for Lutherans now owns 42,190 shares of the company worth $1,408,000 after purchasing an additional 29,018 shares in the last quarter. Finally, Teza Capital Management LLC purchased a new stake in Nu Skin Enterprises stock during Q3 for $241,000. Institutional investors and hedge funds hold 88.20% of the company’s shares.
Nu Skin Enterprises Company Profile
(Get a rating)
Nu Skin Enterprises, Inc develops and distributes beauty and wellness products worldwide. It provides skin care systems, including ageLOC Spa systems, ageLOC Transformation anti-aging skin care systems and ageLOC LumiSpa skin cleansing and treatment devices; and ageLOC Boost, plus a range of other cosmetic and personal care products.
This instant news alert was powered by MarketBeat’s narrative science technology and financial data to provide readers with the fastest and most accurate reports. This story was reviewed by MarketBeat’s editorial team prior to publication. Please send questions or comments about this story to [email protected]
Before you consider Nu Skin Enterprises, you’ll want to hear this.
MarketBeat tracks daily the highest rated and most successful research analysts on Wall Street and the stocks they recommend to their clients. MarketBeat identified the five stocks that top analysts are quietly whispering to their clients to buy now before the market expands…and Nu Skin Enterprises was not on the list.
While Nu Skin Enterprises currently has a “Hold” rating among analysts, top-rated analysts believe these five stocks are better buys.
See the five actions here